Universal Health Services, Inc. (NYSE:UHS) Shares Sold by Achmea Investment Management B.V.

Achmea Investment Management B.V. lessened its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 8.8% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,725 shares of the health services provider's stock after selling 4,403 shares during the quarter. Achmea Investment Management B.V. owned 0.07% of Universal Health Services worth $8,592,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UHS. Norges Bank acquired a new stake in Universal Health Services during the 4th quarter worth approximately $67,964,000. Invesco Ltd. increased its position in Universal Health Services by 25.6% during the 4th quarter. Invesco Ltd. now owns 1,241,340 shares of the health services provider's stock worth $222,721,000 after purchasing an additional 253,385 shares in the last quarter. Amundi increased its position in Universal Health Services by 189.5% during the 4th quarter. Amundi now owns 360,070 shares of the health services provider's stock worth $68,532,000 after purchasing an additional 235,689 shares in the last quarter. Freestone Grove Partners LP acquired a new stake in Universal Health Services during the 4th quarter worth approximately $41,155,000. Finally, AQR Capital Management LLC grew its position in Universal Health Services by 59.4% in the fourth quarter. AQR Capital Management LLC now owns 590,389 shares of the health services provider's stock valued at $105,928,000 after acquiring an additional 219,942 shares in the last quarter. Institutional investors and hedge funds own 86.05% of the company's stock.

Universal Health Services Stock Up 0.4%

UHS stock opened at $178.15 on Friday. The firm has a 50 day simple moving average of $180.83 and a 200-day simple moving average of $181.36. Universal Health Services, Inc. has a twelve month low of $153.99 and a twelve month high of $243.25. The company has a market capitalization of $11.58 billion, a P/E ratio of 10.00, a PEG ratio of 0.72 and a beta of 1.31. The company has a current ratio of 1.32, a quick ratio of 1.23 and a debt-to-equity ratio of 0.67.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The health services provider reported $4.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.36 by $0.48. Universal Health Services had a return on equity of 17.79% and a net margin of 7.44%. The firm had revenue of $4.10 billion for the quarter, compared to analysts' expectations of $4.16 billion. During the same period last year, the business posted $3.70 earnings per share. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. On average, equities research analysts predict that Universal Health Services, Inc. will post 15.92 earnings per share for the current fiscal year.

Universal Health Services Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Monday, June 2nd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend was Monday, June 2nd. Universal Health Services's dividend payout ratio (DPR) is presently 4.49%.

Analyst Ratings Changes

Several brokerages have issued reports on UHS. Baird R W downgraded shares of Universal Health Services from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays increased their price objective on shares of Universal Health Services from $249.00 to $257.00 and gave the company an "overweight" rating in a research report on Tuesday, April 29th. Royal Bank Of Canada lowered their price objective on shares of Universal Health Services from $211.00 to $201.00 and set a "sector perform" rating for the company in a research report on Wednesday, April 30th. Morgan Stanley began coverage on shares of Universal Health Services in a research report on Wednesday, March 26th. They issued an "equal weight" rating and a $200.00 price objective for the company. Finally, Wells Fargo & Company lowered their price objective on shares of Universal Health Services from $230.00 to $225.00 and set an "overweight" rating for the company in a research report on Monday, March 10th. Nine equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $224.77.

Insider Buying and Selling

In other Universal Health Services news, Director Maria Ruderman Singer sold 1,097 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was sold at an average price of $191.48, for a total value of $210,053.56. Following the sale, the director now directly owns 7,884 shares in the company, valued at approximately $1,509,628.32. This trade represents a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 16.40% of the stock is currently owned by company insiders.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.